Frank Ho |
In this exclusive interview Frank Ho, Ph.D., Vice President, EirGenix, speaks to Pharma IQ about the advantages of single-use technology in biomanufacturing and shares his outlook on this growing market, with a special focus on Asia. Ho discusses the key challenges surrounding commercial scale up of disposable solutions, and how to overcome them and shares his insights on the complexity of standardisation for single-use technologies.
Pharma IQ: What are the advantages of...
To continue reading this story Click Here
RECOMMENDED
Digital Transformation in Pharma: Navigating CMO Partnerships and Supply Chain Resilience
2025-01-22
Sustainability and Inclusivity in Pharma Manufacturing: Insights from AstraZeneca’s People Hub
2024-12-11
Upcoming Events
Pharmaceutical Launch Excellence Summit
2 - 3 December, 2025
UK
Register Now |
View Agenda |
Learn More